Treating Slow-Growing Non-Hodgkin Lymphomas (NHL)
May 4, 2021
Topics Covered
We invite you to learn more about:
- Slow-growing non-Hodgkin lymphomas (NHL)
- Treatment advances for slow-growing lymphomas
- Side-effects management
- Ways to effectively communicate with your healthcare team about quality-of-life issues
Program Materials
Speaker
Matthew S. McKinney, MD
Duke University School of Medicine
Department of Medicine
Division of Hematologic Malignancies
Durham, NC
Program Support
Support for this program is provided by Bristol Myers Squibb; Epizyme, Inc.; Genentech, Inc. & Biogen and Pharmacyclics, An AbbVie Company & Janssen Biotech.